Applying the ESMO-Magnitude of Clinical Benefit Scale in real life

per Ciardiello, Fortunato, Tabernero, Josep
Publicat a ESMO Open (2016)

Shortening adjuvant chemotherapy in stage III colon cancer: are we ready for a change?

per Roda, Desamparados, Ciardiello, Fortunato, Cervantes, Andrés
Publicat a ESMO Open (2018)

Towards the era of precision medicine in metastatic colorectal cancer

per Napolitano, Stefania, Troiani, Teresa, Martinelli, Erika, Ciardiello, Fortunato
Publicat a ESMO Open (2020)

Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care

per Martinelli, Erika, Morgillo, Floriana, Troiani, Teresa, Tortora, Giampaolo, Ciardiello, Fortunato
Publicat 2007

Mechanisms of resistance to EGFR-targeted drugs: lung cancer

per Morgillo, Floriana, Della Corte, Carminia Maria, Fasano, Morena, Ciardiello, Fortunato
Publicat a ESMO Open (2016)

Kisspeptin and Cancer: Molecular Interaction, Biological Functions, and Future Perspectives

per Ciaramella, Vincenza, Della Corte, Carminia Maria, Ciardiello, Fortunato, Morgillo, Floriana
Publicat a Front Endocrinol (Lausanne) (2018)

Treatment of esophagogastric junction carcinoma: An unsolved debate

per Orditura, Michele, Galizia, Gennaro, Lieto, Eva, De Vita, Ferdinando, Ciardiello, Fortunato
Publicat a World J Gastroenterol (2015)

ESMO and WHO: 14 years of working in partnership on cancer control

per Ullrich, Andreas, Ciardiello, Fortunato, Bricalli, Gracemarie, Cherny, Nathan I, Eniu, Alexandru
Publicat a ESMO Open (2016)

Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?

per Sgambato, Assunta, Casaluce, Francesca, Maione, Paolo, Rossi, Antonio, Ciardiello, Fortunato, Gridelli, Cesare
Publicat 2014

Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy

per Fasano, Morena, Della Corte, Carminia Maria, Papaccio, Federica, Ciardiello, Fortunato, Morgillo, Floriana
Publicat a J Thorac Oncol (2015)

Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer

per Della Corte, Carminia Maria, Fasano, Morena, Papaccio, Federica, Ciardiello, Fortunato, Morgillo, Floriana
Publicat a Biomedicines (2014)

The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer

per Schettino, Clorinda, Bareschino, Maria A, Maione, Paolo, Rossi, Antonio, Ciardiello, Fortunato, Gridelli, Cesare
Publicat 2008

Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

per Morgillo, Floriana, Martinelli, Erika, Troiani, Teresa, Orditura, Michele, De Vita, Ferdinando, Ciardiello, Fortunato
Publicat 2011

Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

per Troiani, Teresa, Martinelli, Erika, Morgillo, Floriana, Capasso, Anna, Nappi, Anna, Sforza, Vincenzo, Ciardiello, Fortunato
Publicat 2013

Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016

per van Krieken, Han, Deans, Sandi, Hall, Jacqueline A, Normanno, Nicola, Ciardiello, Fortunato, Douillard, Jean-Yves
Publicat a ESMO Open (2016)

Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib

per Sartore-Bianchi, Andrea, Lonardi, Sara, Aglietta, Massimo, Martino, Cosimo, Ciardiello, Fortunato, Marsoni, Silvia, Siena, Salvatore
Publicat a JAMA Oncol (2020)

PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?

per Franzese, Elisena, Diana, Anna, Centonze, Sara, Pignata, Sandro, De Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Publicat a Front Oncol (2020)

How we treat metastatic colorectal cancer

per De Falco, Vincenzo, Napolitano, Stefania, Roselló, Susana, Huerta, Marisol, Cervantes, Andrés, Ciardiello, Fortunato, Troiani, Teresa
Publicat a ESMO Open (2020)

Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence

per Troiani, Teresa, Napolitano, Stefania, Della Corte, Carminia Maria, Martini, Giulia, Martinelli, Erika, Morgillo, Floriana, Ciardiello, Fortunato
Publicat a ESMO Open (2016)

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes

per Diana, Anna, Carlino, Francesca, Franzese, Elisena, Oikonomidou, Olga, Criscitiello, Carmen, De Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Publicat a Cancers (Basel) (2020)